Serum-soluble Fas antigen level in patients with allergic rhinitis: Its relation to specific immunotherapy

Allergy and Asthma Proceedings

Volumn 27, Issue 2, 2006, Pages 145-147

  Kinikli, Gülay ^a   Ateş, Aşkin ^a,b   Turgay, Murat ^a   Aydoǧan, Nergis ^a   Tokgöz, Güner ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DESENSITIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAY FEVER; HUMAN; MALE; MIDDLE AGED; PERENNIAL RHINITIS; PHYSIOLOGY;

ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DESENSITIZATION, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 33646481548     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ucker DS, Myers J, and Obermiller PS. Activation-driven cell death. J Rheumatol 49:1583-1589, 1992.
2. Schwartz RH. Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 184:1-8, 1996.
3. Guerra F, Carracedo J, Madueno JA, et al. Allergens induce apoptosis in lymphocytes from atopic patients. Hum Immunol 60:840-847, 1999.
4. Ebner C. Systemic immune response to specific immunotherapy. Clin Exp Allergy 28:781-783, 1998.
5. Lenardo M, Chan FKM, Hornung F, et al. Mature T lymphocyte apoptosis-Immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17:221-253, 1999.
6. Smith W, and Sly PD. Immunotherapy-Anergy, deviation, or suppression? Clin Exp Allergy 28:911-916, 1998.
7. Trauth BC, Klas C, Peters AMJ, et al. Monoclonal antibody-mediated tumor regression by apoptosis. Science 245:301-305, 1989.
8. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762, 1994.
9. Nozawa K, Kayagaki N, Tokano Y, et al. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum 40:1126-1129, 1997.
10. Midis GP, Shen Y, and Owen-Schaub LB. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res 56:3870-3874, 1996.
11. Kato M, Tamada Y, Kageyama M, et al. Elevated soluble Fas levels in herpes zoster patients. Br J Dermatol 138:1091, 1998.
12. Kato M, Hattori T, Hirotaka I, et al. Serum-soluble Fas levels as a marker to distinguish allergic and nonallergic rhinitis. J Allergy Clin Immunol 103:1213-1214, 1999.
13. Kato M, Nozaki Y, Yoshimoto T, et al. Different serum soluble Fas levels in patients with allergic rhinitis and bronchial asthma. Allergy 54:1299-1302, 1999.
14. Grzegorczyk J, Kowalski ML, Pilat A, et al. Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: Relation to serum markers of apoptosis. Mediators Inflamm 11:225-233, 2002.
15. Spinozzi F, Fizzotti M, Agea E, et al. Defective expression of Fas messenger RNA and Fas receptor on pulmonary T cells from patients with asthma. Ann Intern Med 128:363-369, 1998.
16. Krug N, Tschernig T, Balke K, et al. Enhanced expression of Fas ligand (CD95L) on T cells after segmental allergen provocation in asthma. J Allergy Clin Immunol 103:649-655, 1999.
17. Jayaraman S, Castro M, O'Sullivan M, et al. Resistance to Fas-mediated T cell apoptosis in asthma. J Immunol 162:1717-1722, 1999.
18. Walters CS, Tackey RN, Reece E, et al. Bystander T cells participate in specific response to cockroach antigen (CR) in vitro. Immunol Invest 32:105-118, 2003.